In a phase 3 study, Crovalimab was found to be efficacious and well tolerated in people with paroxys...
Read moreBiopharmas offer significant discounts on their products in China, to try and score spots on the cou...
Read moreJapan’s largest drugmaker Takeda says it aims to seek marketing authorisation for its TAK-755 enzy...
Read moreGermany's BPI and vfa advise that the implementation of the European Health Technology Assessment (E...
Read moreTwo global pharma companies withdraw from the UK’s Voluntary Scheme for Branded Medicines Pricing ...
Read moreNHS England has reported that following a 5-year £1b antiviral drugs deal, deaths from Hepatitis C ...
Read moreFrance have improved the conduction of clinical trials in 2021, due to the reduction of regulatory d...
Read moreNICE guidance published today on digital health technologies suggest they can be used to help young ...
Read moreDigitisation is thought to contribute significant improvements in knowledge generation in drug devel...
Read moreEUCOPE and EFPIA have issued a joint statement expressing concerns regarding the implementation of t...
Read more